IUSV vs. VTVT
Compare and contrast key facts about iShares Core S&P U.S. Value ETF (IUSV) and vTv Therapeutics Inc. (VTVT).
IUSV is a passively managed fund by iShares that tracks the performance of the S&P 900 Value Index. It was launched on Jul 24, 2000.
Performance
IUSV vs. VTVT - Performance Comparison
Loading graphics...
IUSV vs. VTVT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IUSV iShares Core S&P U.S. Value ETF | 0.24% | 12.85% | 12.18% | 21.73% | -5.40% | 25.22% | 1.56% | 31.47% | -9.21% | 15.09% |
VTVT vTv Therapeutics Inc. | 1.35% | 189.60% | 20.08% | -56.62% | -33.39% | -46.51% | 9.41% | -35.85% | -55.91% | 24.43% |
Returns By Period
In the year-to-date period, IUSV achieves a 0.24% return, which is significantly lower than VTVT's 1.35% return. Over the past 10 years, IUSV has outperformed VTVT with an annualized return of 11.61%, while VTVT has yielded a comparatively lower -15.09% annualized return.
IUSV
- 1D
- 0.14%
- 1M
- -4.43%
- YTD
- 0.24%
- 6M
- 3.09%
- 1Y
- 13.16%
- 3Y*
- 13.74%
- 5Y*
- 10.28%
- 10Y*
- 11.61%
VTVT
- 1D
- 2.19%
- 1M
- 13.85%
- YTD
- 1.35%
- 6M
- 68.88%
- 1Y
- 147.13%
- 3Y*
- 7.85%
- 5Y*
- -18.91%
- 10Y*
- -15.09%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IUSV vs. VTVT — Risk / Return Rank
IUSV
VTVT
IUSV vs. VTVT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Core S&P U.S. Value ETF (IUSV) and vTv Therapeutics Inc. (VTVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IUSV | VTVT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.84 | 1.97 | -1.12 |
Sortino ratioReturn per unit of downside risk | 1.27 | 2.48 | -1.21 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.31 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 1.07 | 3.39 | -2.31 |
Martin ratioReturn relative to average drawdown | 4.98 | 6.81 | -1.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IUSV | VTVT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.84 | 1.97 | -1.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.71 | -0.20 | +0.90 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.68 | -0.13 | +0.81 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | -0.17 | +0.76 |
Correlation
The correlation between IUSV and VTVT is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
IUSV vs. VTVT - Dividend Comparison
IUSV's dividend yield for the trailing twelve months is around 1.80%, while VTVT has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IUSV iShares Core S&P U.S. Value ETF | 1.80% | 1.78% | 2.15% | 1.75% | 2.22% | 1.87% | 2.40% | 2.19% | 2.67% | 1.93% | 4.44% | 7.63% |
VTVT vTv Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IUSV vs. VTVT - Drawdown Comparison
The maximum IUSV drawdown since its inception was -56.88%, smaller than the maximum VTVT drawdown of -98.19%. Use the drawdown chart below to compare losses from any high point for IUSV and VTVT.
Loading graphics...
Drawdown Indicators
| IUSV | VTVT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.88% | -98.19% | +41.31% |
Max Drawdown (1Y)Largest decline over 1 year | -12.13% | -39.58% | +27.45% |
Max Drawdown (5Y)Largest decline over 5 years | -17.95% | -94.27% | +76.32% |
Max Drawdown (10Y)Largest decline over 10 years | -37.54% | -97.48% | +59.94% |
Current DrawdownCurrent decline from peak | -4.51% | -90.70% | +86.19% |
Average DrawdownAverage peak-to-trough decline | -6.33% | -77.61% | +71.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.61% | 19.68% | -17.07% |
Volatility
IUSV vs. VTVT - Volatility Comparison
The current volatility for iShares Core S&P U.S. Value ETF (IUSV) is 3.86%, while vTv Therapeutics Inc. (VTVT) has a volatility of 21.27%. This indicates that IUSV experiences smaller price fluctuations and is considered to be less risky than VTVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IUSV | VTVT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.86% | 21.27% | -17.41% |
Volatility (6M)Calculated over the trailing 6-month period | 7.79% | 58.21% | -50.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.67% | 75.53% | -59.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.60% | 96.82% | -82.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.08% | 120.07% | -102.99% |